Overview
We are a biotech startup at the forefront of developing innovative healthcare solutions focused on personalized medicine. Our flagship product is a diagnostic tool that utilizes cutting-edge genetic analysis to tailor treatments for individual patients, significantly improving their effectiveness and outcomes. The market for personalized medicine is rapidly expanding, with projected growth expected to reach $418 billion by 2026. Despite our promising traction, including successful beta testing with clinical partners and positive user feedback from over 1,000 initial patients, we need additional capital to finalize product development, conduct clinical trials, and scale our operations to meet anticipated demand. Our team consists of experienced professionals from pharmaceutical and biotech backgrounds, with expertise in product development, regulatory affairs, and commercialization. We have secured preliminary partnerships with key healthcare providers, which positions us well for market entry. However, to capitalize on this opportunity, we require funding to navigate the next critical stages of our product lifecycle, including securing necessary regulatory approvals and expanding o…
Use of funds
The investment will be allocated as follows:
- 40% for final product development and testing.
- 30% for clinical trials to validate efficacy and safety.
- 20% for marketing strategy development and implementation.
- 10% for operational costs and team expansion.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.